| Adspot Explanations |
|
|
|
For
UBIEE-GAMMA-SOLIXTA-CLASSIC ENVIRO PROJECT - Model tu work with and to learn
its functionalities |
Para
UBIEE-GAMMA-SOLIXTA-CLASSIC ENVIRO PROJECT - Modelo para trabajar y aprender
el funcionamiento |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Group - 100 |
UBIEE HQ |
|
FREE |
|
Contribution |
64% |
Group Total to be Paid |
0,000 € |
|
Paid so far |
0,000 € |
until: |
21/07/2007 |
|
|
New TP1 |
Your Name |
10,00 €[1] |
6,40 € |
Group |
Total Pay |
0,000 € |
|
Paid out: |
|
until: |
21/07/2007 |
|
| ID Continuo |
PosiCion UEP |
GROUP ID |
Group Leader |
64% |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19 |
20 |
21 |
22 |
23 |
24 |
25 |
26 |
27 |
28 |
29 |
30 |
31 |
32 |
33 |
34 |
35 |
36 |
37 |
38 |
39 |
40 |
41 |
42 |
43 |
44 |
45 |
46 |
47 |
48 |
49 |
50 |
51 |
52 |
53 |
54 |
55 |
56 |
57 |
58 |
59 |
60 |
61 |
62 |
63 |
64 |
65 |
|
| 1 |
0 |
TP1 |
OTC16[2] |
64% |
0,000 € |
0,000 € |
Your Name[3] |
0,000 €[4] |
Order your |
UEPAdSpot |
UBIEE |
UBieePill |
Order your |
Order your |
Order your |
VORTEX 1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2 |
1 |
OTC1 |
OTC17[5] |
64% |
10,000 € |
6,400 € |
Name[6] |
0,000 €[7] |
Free
AdSpot |
Free
AdSpot |
UBIEE |
UBieePill |
Free
AdSpot |
Free
AdSpot |
Free
AdSpot |
VORTEX 12 |
Order your |
UEPAdSpot |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 3 |
2 |
OTC2 |
OTC18[8] |
64% |
10,000 € |
3,200 € |
Name[9] |
0,000 €[10] |
Order your |
UEPAdSpot |
Order your |
UEPAdSpot |
Order your |
UEPAdSpot |
Order your |
UEPAdSpot |
Order your |
UEPAdSpot |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 4 |
3 |
OTC3 |
OTC19[11] |
64% |
10,000 € |
2,133 € |
Name[12] |
0,000 €[13] |
|
Free
AdSpot |
Order your |
UEPAdSpot |
Order your |
Order your |
UEPAdSpot |
Order your |
UEPAdSpot |
Order your |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 5 |
4 |
OTC4 |
OTC20[14] |
64% |
10,000 € |
1,600 € |
Name[15] |
0,000 €[16] |
|
Free
AdSpot |
Order your |
VORTEX 1 |
Order your |
UEPAdSpot |
|
|
Order your |
UEPAdSpot |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 6 |
5 |
OTC5 |
OTC21[17] |
64% |
10,000 € |
1,280 € |
Name[18] |
0,000 €[19] |
|
Free
AdSpot |
Order your |
UEPAdSpot |
|
|
Order your |
UEPAdSpot |
Order your |
UEPAdSpot |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 7 |
6 |
OTC6 |
OTC22[20] |
64% |
10,000 € |
1,067 € |
Name[21] |
0,000 €[22] |
|
Free
AdSpot |
Order your |
UEPAdSpot |
VORTEX 1 |
|
UEPAdSpot |
Order your |
UEPAdSpot |
Order your |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 8 |
7 |
OTC7 |
OTC23[23] |
64% |
10,000 € |
0,914 € |
Name[24] |
0,000 €[25] |
Order your |
UEPAdSpot |
Order your |
UEPAdSpot |
UEPAdSpot |
|
UEPAdSpot |
Order your |
UEPAdSpot |
Order your |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 9 |
8 |
OTC8 |
OTC24[26] |
64% |
10,000 € |
0,800 € |
Name[27] |
0,000 €[28] |
|
Free
AdSpot |
|
|
Free
AdSpot |
VORTEX 13 |
Free
AdSpot |
VORTEX 14 |
Free
AdSpot |
UEPAdSpot |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 10 |
9 |
OTC9 |
OTC25[29] |
64% |
10,000 € |
0,711 € |
Name[30] |
0,000 €[31] |
|
Free
AdSpot |
|
|
Free
AdSpot |
VORTEX 14 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 11 |
10 |
OTC10 |
OTC26[32] |
64% |
10,000 € |
0,640 € |
Name |
0,000 €[33] |
|
Free
AdSpot |
|
|
Free
AdSpot |
VORTEX 15 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 12 |
11 |
OTC11 |
OTC27[34] |
64% |
10,000 € |
0,582 € |
Name |
0,000 €[35] |
|
Free
AdSpot |
|
|
Free
AdSpot |
VORTEX 16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 13 |
12 |
OTC12 |
OTC28[36] |
64% |
10,000 € |
0,533 € |
Name |
0,000 €[37] |
|
Advertising Examples |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 14 |
13 |
OTC13 |
OTC29[38] |
64% |
10,000 € |
0,492 € |
Name |
0,000 €[39] |
|
|
|
UBIEE |
UBieePill |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 15 |
14 |
OTC14 |
OTC30[40] |
64% |
10,000 € |
0,457 € |
Name |
0,000 €[41] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 16 |
15 |
OTC15 |
OTC31[42] |
64% |
10,000 € |
0,427 € |
Name |
0,000 €[43] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 17 |
16 |
OTC16[44] |
OTC32[45] |
64% |
10,000 € |
0,400 € |
Name |
0,000 €[46] |
|
|
EXAMPLE:From OTC1 to OTC128 we have 12 Ad-Spots per line to offer for Publishers |
UBIEE ENVIRO AMBASSADORS |
|
|
UBIEE ENVIRO TEAMS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 18 |
17 |
OTC17 |
OTC33[47] |
64% |
10,000 € |
0,376 € |
Name |
0,000 €[48] |
OTC34[49] |
|
Implemented
NOW: Example for the future adspots in UEP-GEP-SEP-CEP |
This
is the complete Disbursement plan generated from Ad-Spots |
Leaders |
GIAs |
Distributors |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 19 |
18 |
OTC18 |
OTC34[50] |
64% |
10,000 € |
0,356 € |
Name |
0,000 €[51] |
OTC35 |
|
Starting Line Grids
Example |
Maximum |
64,00% |
4,00% |
60,00% |
10,00% |
10,00% |
10,00% |
10,00% |
10,00% |
10,00% |
15,00% |
10,00% |
15,00% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|